Clinical Trial Update: Efficacy and Safety of Oral Regimens for the Treatment of Chronic HCV Infection [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating oral regimens for chronic hepatitis C showed efficacy and safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: Gilead Sciences | Conditions: Chronic Hepatitis C | Phase 2 | Status: COMPLETED | Results posted: 2017-11-17